SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aptus Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

544529

INE15XJ01010

29.1342566

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

109.76

EPS(TTM)

Face Value()

Div & Yield %

Back

aptus pharma ltd

Aptus Pharma Ltd - Other Announcements

Sep 30,2025

In continuation to the Exchanges Notice No. 20250929-80 dated Monday, September 29, 2025, Trading Members are hereby informed that the trading in the equity shares of Aptus Pharma Limited-SME IPO (Scrip Code: 544529) shall be transferred from Trade for Trade segment (MT Group) to Rolling segment with effect from Wednesday, October 15, 2025. Accordingly, the dealings in the equity shares of the company will be shifted under M Group.

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)